Get the Stockscreener App
6.45
1.07%
-0.07
After Hours:
6.45
Treace Medical Concepts Inc stock is traded at $6.45, with a volume of 406.72K.
It is down -1.07% in the last 24 hours and down -19.07% over the past month.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.
See More
Previous Close:
$6.52
Open:
$6.47
24h Volume:
406.72K
Relative Volume:
1.02
Market Cap:
$421.72M
Revenue:
$198.53M
Net Income/Loss:
$-63.68M
P/E Ratio:
-6.3099
EPS:
-1.0222
Net Cash Flow:
$-41.50M
1W Performance:
-7.73%
1M Performance:
-19.07%
6M Performance:
+21.93%
1Y Performance:
-43.42%
1-Day Range:
$6.40
$6.60
1-Week Range:
$6.39
$7.09
52-Week Range:
$3.92
$11.51
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Name
Treace Medical Concepts Inc
Sector
Industry
Phone
(904) 373-5940
Address
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
6.45 | 421.72M | 198.53M | -63.68M | -41.50M | -1.0222 |
|
ABT
Abbott Laboratories
|
130.98 | 221.92B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
95.12 | 139.43B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
346.50 | 134.90B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
82.60 | 108.02B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
71.53 | 40.93B | 5.72B | 4.17B | 259.90M | 6.97 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-04-25 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-31-24 | Initiated | Lake Street | Buy |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-16-24 | Downgrade | UBS | Buy → Neutral |
| May-08-24 | Downgrade | BTIG Research | Buy → Neutral |
| May-08-24 | Downgrade | JP Morgan | Overweight → Neutral |
| May-08-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| May-08-24 | Downgrade | Stifel | Buy → Hold |
| May-08-24 | Downgrade | Truist | Buy → Hold |
| Sep-29-23 | Initiated | UBS | Buy |
| May-01-23 | Initiated | Truist | Buy |
| Apr-11-23 | Initiated | Stephens | Equal-Weight |
| May-12-22 | Initiated | BTIG Research | Buy |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| May-18-21 | Initiated | JP Morgan | Overweight |
| May-18-21 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-21 | Initiated | SVB Leerink | Outperform |
| May-18-21 | Initiated | Stifel | Buy |
View All
Treace Medical Concepts Inc Stock (TMCI) Latest News
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Treace Medical Concepts, Inc. Investors to - Bluefield Daily Telegraph
ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI - GlobeNewswire Inc.
Press Release Distribution & PR Platform - ACCESS Newswire
TMCI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Treace Medical Concepts, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
Levi & Korsinsky Reminds Treace Medical Concepts, Inc. Investors of the Pending Class ... - Bluefield Daily Telegraph
Shareholders of Treace Medical Concepts, Inc. Should Contact Levi & Korsinsky Before June 10, 2025 to Discuss Your RightsTMCI - MarketScreener
Lawsuit filed for Investors who lost money with shares of Treace Medical Concepts, Inc. (NASDAQ: TMCI) - openPR.com
TMCI Stockholder Notice: Robbins LLP Reminds Shareholders - GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Treace Medical - Bluefield Daily Telegraph
TMCI LAWSUIT ALERT: The Gross Law Firm Notifies Treace - GlobeNewswire
TMCI LAWSUIT ALERT: The Gross Law Firm Notifies Treace Medical Concepts, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - TradingView
Grabar Law Office Investigates Claims on Behalf of - GlobeNewswire
Grabar Law Office Investigates Claims on Behalf of Long-Term Shareholders of BioAge Labs, Inc. (NASDAQ: BIOA); NAPCO Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NASDAQ: VI - TradingView
Treace Medical Concepts, Inc. Securities Fraud Class Action Lawsuit Pending: Contact The Gross Law Firm Before June 10, 2025 to Discuss Your RightsTMCI - MarketScreener
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) INVESTOR - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Treace Medical - GlobeNewswire
ROSEN, LEADING INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure - Bluefield Daily Telegraph
ROSEN, LEADING INVESTOR COUNSEL, Encourages Treace Medical Concepts, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – TMCI - TradingView
Law Offices of Howard G. Smith Encourages Treace Medical Concepts, Inc. (TMCI) Investors To Inquire About Securities Fraud Class Action - Business Wire
Truist Financial Has Lowered Expectations for Treace Medical Concepts (NASDAQ:TMCI) Stock Price - MarketBeat
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) INVESTOR ALERT: Investors With Large Losses in - Bluefield Daily Telegraph
TREACE MEDICAL CONCEPTS, INC. (NASDAQ: TMCI) INVESTOR ALERT: Investors With Large Losses in Treace Medical Concepts, Inc. Should Contact Bernstein Liebhard LLP To Discuss Their Rights - TradingView
TMCI Investors Have the Opportunity to Lead the Treace Medical Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar
Treace Medical Concepts, Inc. Investors: Please contact the - GlobeNewswire
TMCI INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
TMCI Investors with Losses in Excess of $100K Have Opportunity to Lead Treace Medical Concepts, Inc. Securities Fraud Lawsuit - Lelezard
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Position Trimmed by Vanguard Group Inc. - Defense World
Treace Medical Concepts, Inc. (NASDAQ:TMCI) Shares Purchased by JPMorgan Chase & Co. - MarketBeat
Investor Alert: Robbins LLP Informs Investors of the Treace Medical Concepts, Inc. Class Action Lawsuit - PR Newswire
TMCI SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Treace Medical Concepts, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - markets.businessinsider.com
Rosen Law Firm Urges Treace Medical Concepts, Inc. (NASDAQ: TMCI) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights - Bluefield Daily Telegraph
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Treace Medical Concepts, Inc. (TMCI) - TradingView
Corebridge Financial Inc. Sells 1,831 Shares of Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
65,800 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Purchased by Norges Bank - MarketBeat
JPMorgan Chase & Co. Increases Holdings in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - Defense World
Raymond James Financial Inc. Invests $392,000 in Treace Medical Concepts, Inc. (NASDAQ:TMCI) - MarketBeat
Treace Medical Concepts, Inc. Investigated Regarding Potential Securities Law ViolationsContact Levi & Korsinsky for DetailsTMCI - ACCESS Newswire
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Treace Medical - GlobeNewswire
Scott+Scott Attorneys at Law LLP Files Securities Class Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI) - Business Wire
Truist Cuts Price Target on Treace Medical Concepts to $8 From $9.50, Keeps Hold Rating - MarketScreener
Treace Medical Concepts Insiders Up US$3.0m On US$7.83m Investment - simplywall.st
52,742 Shares in Treace Medical Concepts, Inc. (NASDAQ:TMCI) Acquired by Raymond James Financial Inc. - Defense World
Treace Medical Concepts names John Treace as chair - MSN
Treace Medical Concepts: No Solid Footing (NASDAQ:TMCI) - Seeking Alpha
Treace Medical appoints John Treace as chairman of the board - MSN
Treace Medical Concepts Inc Stock (TMCI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Treace Medical Concepts Inc Stock (TMCI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Scanlan Sean F. | Chief Innovation Officer |
Mar 17 '25 |
Sale |
7.97 |
50,000 |
398,460 |
364,081 |
1.01%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):